Stock 1801 INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Innovent Biologics, Inc.

Equities

1801

KYG4818G1010

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:17 2024-05-17 am EDT 		5-day change 1st Jan Change
40.05 HKD +0.63% Intraday chart for Innovent Biologics, Inc. -1.23% -6.32%
May. 07 Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC) as Monotherapy for Advanced Gastric Cancer CI
Apr. 30 Innovent Biologics, Inc. Reports Revenue Results for the First Quarter of 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Innovent Biologics, Inc. Appoints Samuel Zhang as Global Chief Business Officer
CI
Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer
CI
Innovent Biologics, Inc. Announces Appointment of Shun Lu as Independent Non-Executive Director and A Member of the Strategy Committee
CI
Innovent Biologics Names New CFO
MT
Innovent Appoints Gary Zieziula as Independent Non-Executive Director
CI
Innovent Biologics, Inc. Announces Executive Changes
CI
Innovent Announces the Establishment of the Scientific Advisory Board
CI
Innovent Biologics, Inc. Announces the Appointment of Dr. Yong Jun Liu as the President of the Group
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. News Innovent Biologics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW